Samidorphan (ALKS 33) is a selective opioid antagonist which blocks the μ-opioid receptor but without affecting the δ-opioid or κ-opioid receptors. It has been investigated for the treatment of alcoholism and cocaine addiction showing similar efficacy to naltrexone but possibly with reduced side effects.
This page contains content from the copyrighted Wikipedia article "Samidorphan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
